Bangkok Dusit Medical Services Public Co. Ltd.(TH:BDMS)
฿20.10+0.10 (+0.50%)
TH:BDMS
Bangkok Dusit Medical Services Public Co. Ltd. financials statements
฿20.10
At close:+0.10 (+0.50%)
Bangkok Dusit Medical Services Public Co. Ltd. (BDMS) Ratios
1 Followers
Bangkok Dusit Medical Services Public Co. Ltd. Ratios
TH:BDMS's free cash flow for Q2 2026 was ฿2.62B. For the 2026 fiscal year, TH:BDMS's free cash flow was decreased by ฿-1.95B and operating cash flow was ฿4.56B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.98 | 1.07 | 1.28 | 1.35 | 1.54 |
| Quick Ratio | 0.83 | 0.96 | 1.15 | 1.24 | 1.41 |
| Cash Ratio | 0.27 | 0.33 | 0.42 | 0.61 | 0.69 |
| Solvency Ratio | 0.47 | 0.46 | 0.45 | 0.39 | 0.35 |
| Operating Cash Flow Ratio | 0.99 | 1.04 | 1.13 | 0.98 | 0.92 |
| Short-Term Operating Cash Flow Coverage | 3.61 | 5.10 | 8.31 | 3.66 | 4.58 |
| Net Current Asset Value | ฿ -24.84B | ฿ -23.93B | ฿ -21.18B | ฿ -20.03B | ฿ -16.29B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.11 | 0.12 | 0.13 | 0.17 | 0.15 |
| Debt-to-Equity Ratio | 0.17 | 0.18 | 0.19 | 0.26 | 0.22 |
| Debt-to-Capital Ratio | 0.14 | 0.16 | 0.16 | 0.21 | 0.18 |
| Long-Term Debt-to-Capital Ratio | 0.03 | 0.06 | 0.08 | 0.10 | 0.13 |
| Financial Leverage Ratio | 1.49 | 1.51 | 1.51 | 1.57 | 1.53 |
| Debt Service Coverage Ratio | 3.15 | 4.68 | 6.96 | 3.21 | 3.97 |
| Interest Coverage Ratio | 51.78 | 47.33 | 34.64 | 26.88 | 15.41 |
| Debt to Market Cap | 0.03 | 0.03 | 0.02 | 0.03 | 0.04 |
| Interest Debt Per Share | 1.12 | 1.18 | 1.18 | 1.52 | 1.23 |
| Net Debt to EBITDA | 0.44 | 0.41 | 0.41 | 0.47 | 0.45 |
| Profitability Margins | |||||
| Gross Profit Margin | 34.91% | 36.89% | 37.12% | 36.55% | 33.56% |
| EBIT Margin | 16.56% | 19.25% | 18.95% | 18.57% | 15.18% |
| EBITDA Margin | 22.70% | 24.93% | 24.75% | 25.04% | 23.67% |
| Operating Profit Margin | 16.56% | 19.02% | 18.78% | 18.48% | 15.08% |
| Pretax Profit Margin | 17.99% | 18.85% | 18.49% | 17.93% | 14.23% |
| Net Profit Margin | 14.21% | 14.82% | 14.25% | 13.71% | 10.66% |
| Continuous Operations Profit Margin | 14.68% | 15.26% | 14.77% | 14.37% | 11.38% |
| Net Income Per EBT | 78.99% | 78.63% | 77.07% | 76.49% | 74.91% |
| EBT Per EBIT | 108.66% | 99.11% | 98.50% | 97.00% | 94.35% |
| Return on Assets (ROA) | 10.03% | 10.55% | 10.01% | 8.91% | 6.18% |
| Return on Equity (ROE) | 14.97% | 15.98% | 15.09% | 14.03% | 9.47% |
| Return on Capital Employed (ROCE) | 13.74% | 15.84% | 15.13% | 14.05% | 9.97% |
| Return on Invested Capital (ROIC) | 10.67% | 12.42% | 11.82% | 10.73% | 7.76% |
| Return on Tangible Assets | 11.51% | 12.14% | 11.57% | 10.30% | 7.24% |
| Earnings Yield | 5.17% | 4.11% | 3.26% | 2.74% | 2.17% |
| Efficiency Ratios | |||||
| Receivables Turnover | 9.30 | 9.02 | 8.95 | 8.97 | 8.68 |
| Payables Turnover | 14.24 | 13.79 | 14.11 | 13.90 | 13.78 |
| Inventory Turnover | 21.21 | 26.15 | 26.21 | 26.38 | 24.67 |
| Fixed Asset Turnover | 1.02 | 1.04 | 1.04 | 1.00 | 0.90 |
| Asset Turnover | 0.71 | 0.71 | 0.70 | 0.65 | 0.58 |
| Working Capital Turnover Ratio | 198.10 | 31.92 | 16.41 | 11.69 | 5.45 |
| Cash Conversion Cycle | 30.82 | 27.93 | 28.82 | 28.25 | 30.38 |
| Days of Sales Outstanding | 39.23 | 40.44 | 40.77 | 40.68 | 42.07 |
| Days of Inventory Outstanding | 17.21 | 13.96 | 13.93 | 13.84 | 14.80 |
| Days of Payables Outstanding | 25.62 | 26.48 | 25.88 | 26.27 | 26.49 |
| Operating Cycle | 56.44 | 54.40 | 54.69 | 54.52 | 56.87 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.48 | 1.44 | 1.31 | 1.28 | 0.92 |
| Free Cash Flow Per Share | 0.82 | 0.71 | 0.79 | 0.96 | 0.64 |
| Dividend Paid and CapEx Coverage Ratio | 1.05 | 1.01 | 1.11 | 1.56 | 0.85 |
| Capital Expenditure Coverage Ratio | 2.25 | 1.97 | 2.50 | 4.00 | 3.33 |
| Operating Cash Flow Coverage Ratio | 1.34 | 1.25 | 1.15 | 0.86 | 0.77 |
| Operating Cash Flow to Sales Ratio | 0.21 | 0.21 | 0.21 | 0.22 | 0.20 |
| Free Cash Flow Yield | 4.25% | 2.90% | 2.84% | 3.30% | 2.79% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 19.30 | 24.26 | 30.83 | 36.71 | 46.00 |
| Price-to-Sales (P/S) Ratio | 2.75 | 3.61 | 4.37 | 5.01 | 4.91 |
| Price-to-Book (P/B) Ratio | 2.90 | 3.89 | 4.63 | 5.13 | 4.36 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 23.53 | 34.53 | 35.20 | 30.33 | 35.87 |
| Price-to-Operating Cash Flow Ratio | 13.08 | 16.96 | 21.22 | 22.74 | 25.10 |
| Price-to-Earnings Growth (PEG) Ratio | -19.49 | 1.98 | 2.21 | 0.63 | 4.14 |
| Enterprise Value Multiple | 12.56 | 14.88 | 18.08 | 20.49 | 21.19 |
| Enterprise Value | 317.86B | 400.34B | 451.34B | 471.79B | 373.41B |
| EV to EBITDA | 12.56 | 14.88 | 18.08 | 20.49 | 21.19 |
| EV to Sales | 2.85 | 3.71 | 4.48 | 5.13 | 5.02 |
| EV to Free Cash Flow | 24.39 | 35.50 | 36.03 | 31.05 | 36.64 |
| EV to Operating Cash Flow | 13.56 | 17.44 | 21.72 | 23.28 | 25.64 |
| Tangible Book Value Per Share | 5.64 | 5.29 | 5.00 | 4.69 | 4.34 |
| Shareholders’ Equity Per Share | 6.66 | 6.29 | 5.99 | 5.66 | 5.28 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.18 | 0.19 | 0.20 | 0.20 | 0.20 |
| Revenue Per Share | 7.02 | 6.79 | 6.35 | 5.78 | 4.68 |
| Net Income Per Share | 1.00 | 1.01 | 0.90 | 0.79 | 0.50 |
| Tax Burden | 0.79 | 0.79 | 0.77 | 0.76 | 0.75 |
| Interest Burden | 1.09 | 0.98 | 0.98 | 0.97 | 0.94 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.20 | 0.19 | 0.20 | 0.19 | 0.20 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.48 | 1.13 | 1.11 | 1.23 | 1.37 |
Currency in THB
